Answers are grounded in this paper and cite their sources.
Multicenter trial examines impacts of bovine colostrum on sepsis in premature infants, indicating no significant outcomes.
Aim: Neonatal sepsis and necrotizing enterocolitis (NEC) have a great impact on morbidity and mortality in immature newborns. We performed our trial to examine the impact of enteral bovine colostrum administration upon late neonatal sepsis in premature newborns. Patients &Procedures: The study included neonates who had a birth weight (BW) of 1-1.8 kg, a gestational age (GA) of full 28-34 weeks, and a postnatal age of ≤ 96 hours. A blinded, randomized, placebo-controlled study was done using two groups; one of them received bovine colostrum daily within the first 96 hours starting from the 2nd day of feeding and for 14 days, while the other group received a placebo. The primary outcomes evaluated were sepsis; the secondary outcomes encompassed necrotizing enterocolitis, duration until complete enteral feeding, length of hospitalization, and overall death. Results: The study included 35 participants, comprising 16 infants receiving bovine colostrum and 19 receiving a placebo. The baseline demographic criteria and clinical features of the groups were balanced. Late sepsis occurred in 25.0% of the bovine colostrum group compared with 10.5% in the control group (p = 0.258). No reported definite necrotizing enterocolitis (NEC) cases in either group (p = 0.612). However, suspected NEC was observed in 6.2% of the bovine colostrum group, while none were reported in the control group (p = 0.269). The median time to full feeding was 8.0 days (IQR: 6.0-11.0) for the bovine colostrum group and 7.0 days (IQR: 5.5-9.0) for the non-intervention group (p = 0.404). The median duration of hospitalization was 22.5 days (IQR: 13.0-29.8) for the bovine colostrum group and 24.0 days (IQR: 20.5-30.0) for the control group (p = 0.596). Allcause mortality was recorded at 12.5% in the bovine colostrum group and none in the control group (p = 0.112). Conclusion: Our investigation revealed no significant differences in the incidence of confirmed or suspected sepsis and NEC, duration until ull enteral feeding, length of hospital admissions, or all-cause death in comparison to placebo.
No takes yet. Share an insight, caveat, or question.
Michael et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: